Roswell Park Study First to Show Two-Drug Combination Selectively Targets p53-Mutant Cancers
Thymidine analog TAS102 plus PARP inhibitor inhibits growth of colon, pancreatic tumors PARP...
Read MoreFeb 27, 2024 | All Articles, Cancer, Cancer, Gastrointestinal Health, Health, News, Research | 0 |
Thymidine analog TAS102 plus PARP inhibitor inhibits growth of colon, pancreatic tumors PARP...
Read MoreFeb 23, 2024 | All Articles, Cancer, COPD/Respiratory, Health, News | 0 |
Newly released report pulls data from NYS Cancer Registry, US Census and recent research 144...
Read MoreHillengass headlines podium presentation at 2024 Tandem Meetings in San Antonio Data updated on...
Read MoreFeb 2, 2024 | All Articles, Cancer, Cancer, COPD/Respiratory, COVID-19, Health, Immunizations | 0 |
Courtesy of Roswell Park’s Patient Education Department Preventing infection is a top priority for...
Read MoreJan 18, 2024 | All Articles, Cancer, Cancer, COPD/Respiratory, Health, News | 0 |
Dr. Sai Yendamuri joins leadership board, earns service award and receives mentorship grant...
Read MoreCourtesy of Roswell Park Comprehensive Cancer Center Cancer Talk Circumstances surrounding...
Read MoreDec 12, 2023 | All Articles, Cancer, Cancer, Careers and Education, Community, Health, Lifestyle, News | 0 |
Drs. Brian Betts, Shernan Holtan and Kanwaldeep Mallhi named to leadership roles within emerging...
Read MoreAnalysis of treatment response among more than 100,000 people underscores need for personalized...
Read More